New Studies Link GLP-1 Drugs for Diabetes and Obesity to Rare but Real Hair Loss Risk

People taking GLP-1 drugs like Ozempic and Wegovy face a real — if rare — risk of hair loss, new research shows. The risk is higher than with other diabetes medications, according to studies from the University of Pennsylvania and the American Academy of Dermatology, as reported by Greensboro News & Record.
GLP-1 drugs have surged in popularity for treating obesity and type 2 diabetes. Millions of Americans now take them. But researchers say hair loss is a side effect that patients and doctors should know about, even though most people will not experience it.
The studies compared hair loss rates in people on GLP-1 drugs versus those on other diabetes or weight-loss treatments. GLP-1 users had a notably higher rate of hair loss, Omaha World-Herald reported. The exact numbers varied by study, but the pattern was consistent across both research efforts.
The type of hair loss seen is called telogen effluvium. That is a condition where stress on the body causes hair follicles to stop growing and shed faster than normal. It is often temporary. Hair can grow back once the body adjusts.
Experts say the hair loss may not be caused directly by the drug itself. Instead, it may be a side effect of losing weight very quickly. Rapid weight loss puts physical stress on the body. That stress can trigger telogen effluvium, La Crosse Tribune reported.
GLP-1 drugs work by curbing appetite and slowing digestion. Users often lose weight faster than with diet alone. That speed may be what pushes some patients into hair shedding. Doctors say eating enough protein during weight loss may help reduce the risk.
Researchers stressed that hair loss is not common among GLP-1 users. The overall risk is low. But it is still higher than what is seen with other drugs used to treat the same conditions, according to Fredericksburg.com.
Doctors say patients should not stop taking their medication over fear of hair loss. The benefits of GLP-1 drugs — including lower blood sugar and significant weight loss — often outweigh the risks. Patients who notice heavy shedding should talk to their doctor, Kearney Hub reported.
GLP-1 drugs are already known to cause nausea, vomiting, and stomach issues in some users. Hair loss now joins that list as a documented — though uncommon — side effect, Channel 3000 reported. The findings come from two independent research teams, adding weight to the conclusion.
Both the University of Pennsylvania and the American Academy of Dermatology contributed to the research. Their work is expected to help doctors better counsel patients before they start GLP-1 therapy. More studies are planned to understand exactly how and why hair loss occurs in some users.
Publishers
9
Articles
9
Reach
9